Inventor · disambiguated record
Iain Mcfadyen
Also filed as: MCFADYEN IAIN · MCFADYEN IAIN JAMES
31 granted patents·24 pending applications·143 citations·filing 2008–2024
97Inventor score
Files withMODERNATX INC46LIFEMINE THERAPEUTICS INC4FLAGSHIP PIONEERING INNOVATIONS VII LLC2MODERNA TX INC2LI WEI1
Top patents by PatentIndex Score
55 records- 0198US11344504B1Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2021·Granted May 31, 2022·4 cites·29 claims
- 0298US10285950B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted May 14, 2019·13 cites·20 claims
- 0398US10172808B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Jan 8, 2019·19 cites·18 claims
- 0497US11851694B1High fidelity in vitro transcriptionMODERNATX INC·Filed 2020·Granted Dec 26, 2023·20 cites·15 claims
- 0597US11071716B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2020·Granted Jul 27, 2021·3 cites·20 claims
- 0697US10646549B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2018·Granted May 12, 2020·13 cites·20 claims
- 0796US11000573B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2020·Granted May 11, 2021·3 cites·20 claims
- 0896US10406113B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Sep 10, 2019·7 cites·30 claims
- 0995US11596609B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2022·Granted Mar 7, 2023·1 cites·20 claims
- 1095US11504337B2Polynucleotides encoding methylmalonyl-CoA mutaseMODERNATX INC·Filed 2019·Granted Nov 22, 2022·12 cites·19 claims
- 1195US10322090B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Jun 18, 2019·5 cites·30 claims
- 1295US10322091B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Jun 18, 2019·5 cites·30 claims
- 1392US10973917B2MRNA combination therapy for the treatment of cancerMODERNATX INC·Filed 2019·Granted Apr 13, 2021·4 cites·27 claims
- 1492US10335486B2MRNA combination therapy for the treatment of cancerMODERNATX INC·Filed 2018·Granted Jul 2, 2019·8 cites·23 claims
- 1591US11001861B2Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1MODERNATX INC·Filed 2017·Granted May 11, 2021·11 cites·50 claims
- 1691US10494636B2Polynucleotides encoding α-galactosidase A for the treatment of Fabry diseaseMODERNATX INC·Filed 2018·Granted Dec 3, 2019·3 cites·8 claims
- 1790US11311602B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2021·Granted Apr 26, 2022·1 cites·31 claims
- 1889US11185510B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2019·Granted Nov 30, 2021·1 cites·26 claims
- 1988US10730924B2Polynucleotides encoding relaxinMODERNATX INC·Filed 2018·Granted Aug 4, 2020·5 cites·21 claims
- 2084US11649461B2Polynucleotides encoding α-galactosidase A for the treatment of Fabry diseaseMODERNATX INC·Filed 2019·Granted May 16, 2023·1 cites·21 claims
- 2184US10993918B2Polynucleotides encoding citrin for the treatment of Citrullinemia type 2MODERNATX INC·Filed 2017·Granted May 4, 2021·2 cites·50 claims
- 2283US2023041964A1Combinations of mrnas encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2022·Application pending·0 cites
- 2382US11801227B2Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosisMODERNATX INC·Filed 2017·Granted Oct 31, 2023·1 cites·30 claims
- 2482US11571463B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2022·Granted Feb 7, 2023·0 cites·23 claims
- 2582US2024024422A1Polynucleotides encoding interleukin-12 (il12) and uses thereofMODERNATX INC·Filed 2023·Application pending·0 cites
- 2682US2023323371A1Polynucleotides encoding alpha-galactosidase a for the treatment of fabry diseaseMODERNATX INC·Filed 2023·Application pending·0 cites
- 2782US2023270685A1POLYNUCLEOTIDES ENCODING METHYLMALONYL-CoA MUTASEMODERNATX INC·Filed 2022·Application pending·0 cites
- 2881US2023346928A1Mrna combination therapy for the treatment of cancerMODERNATX INC·Filed 2023·Application pending·0 cites
- 2980US2025069699A1Methods and Systems for Discovery of Embedded Target Genes in Biosynthetic Gene ClustersLIFEMINE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3080US2025037800A1Methods and systems for identifying genes associated with biosynthetic gene clustersLIFEMINE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3178US10519455B2Polynucleotides encoding alpha-galactosidase A for the treatment of Fabry diseaseMODERNATX INC·Filed 2018·Granted Dec 31, 2019·1 cites·29 claims
- 3277US2024318187A1Polyribonucleotides containing reduced uracil content and uses thereofMODERNATX INC·Filed 2023·Application pending·0 cites
- 3376US11660341B2mRNA combination therapy for the treatment of cancerMODERNATX INC·Filed 2021·Granted May 30, 2023·0 cites·31 claims
- 3475US12377136B2Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyriaMODERNATX INC·Filed 2022·Granted Aug 5, 2025·0 cites·11 claims
- 3573US2023250439A1Polynucleotide secondary structureMODERNATX INC·Filed 2023·Application pending·0 cites
- 3672US2024238210A1Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosisMODERNA TX INC·Filed 2023·Application pending·0 cites
- 3771US2025078956A1Methods And Systems For Discovery Of Non-Embedded Target GenesLIFEMINE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3870US2023146324A1Multiparametric nucleic acid optimizationMODERNATX INC·Filed 2022·Application pending·0 cites
- 3969US12252704B2Polynucleotides encoding galactose-1-phosphate uridylyltransferase for the treatment of galactosemia type 1MODERNATX INC·Filed 2021·Granted Mar 18, 2025·0 cites·23 claims
- 4068US12239742B2Polynucleotides encoding Citrin for the treatment of Citrullinemia type 2MODERNATX INC·Filed 2021·Granted Mar 4, 2025·0 cites·3 claims
- 4168US2025069701A1Deep Learning Methods For Biosynthetic Gene Cluster DiscoveryLIFEMINE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4265US12103955B2Polynucleotides encoding relaxinMODERNATX INC·Filed 2020·Granted Oct 1, 2024·0 cites·27 claims
- 4362US2025092426A1Cas endonucleases and related methodsFLAGSHIP PIONEERING INNOVATIONS VII LLC·Filed 2024·Application pending·0 cites
- 4462US2025092375A1Cas endonucleases and related methodsFLAGSHIP PIONEERING INNOVATIONS VII LLC·Filed 2024·Application pending·0 cites
- 4554US2020085916A1Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyriaMODERNATX INC·Filed 2017·Application pending·0 cites
- 4653US2019382774A1Polyribonucleotides containing reduced uracil content and uses thereofMODERNATX INC·Filed 2017·Application pending·0 cites
- 4752US2017362627A1Multiparametric nucleic acid optimizationMODERNATX INC·Filed 2015·Application pending·0 cites
- 4851US2020032274A1Polynucleotide secondary structureMODERNA TX INC·Filed 2018·Application pending·0 cites
- 4949US12128113B2Polynucleotides encoding JAGGED1 for the treatment of Alagille syndromeMODERNATX INC·Filed 2017·Granted Oct 29, 2024·0 cites·32 claims
- 5045US12123030B2Polynucleotides encoding lipoprotein lipase for the treatment of hyperlipidemiaMODERNATX INC·Filed 2017·Granted Oct 22, 2024·0 cites·55 claims
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Iain Mcfadyen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →